Aethlon Medical (AEMD) Return on Sales (2011 - 2023)

Aethlon Medical's Return on Sales history runs 13 years deep, the most recent figure standing at 0.57% for Q1 2023.

• Quarterly Return on Sales rose 2297.0% year-over-year to 0.57% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.73% (up 62.0% YoY) and the FY2023 annual result came in at 0.73%, up 55.0% from the prior year.
• Return on Sales was 0.57% for Q1 2023 at Aethlon Medical, up from 30.72% in the prior quarter.
• Across five years, Return on Sales topped out at 0.02% in Q4 2019 and bottomed at 30.72% in Q4 2022.
• A 5-year average of 4.4% and a median of 0.55% in 2019 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales slumped 2925 bps — and 2023, when it jumped 2297 bps.
• Aethlon Medical's Return on Sales stood at 0.02% in 2019, then tumbled by 144 bps to 0.05% in 2020, then plunged by 2739 bps to 1.48% in 2021, then sank by 1980 bps to 30.72% in 2022, then jumped by 98 bps to 0.57% in 2023.
• Business Quant data shows AEMD's Return on Sales at 0.57% in Q1 2023, 30.72% in Q4 2022, and 13.22% in Q3 2022.